HIF1A and neoplasm: Moreover, Liu et al. have demonstrated that gene transfer of antisense HIF-1α downregulates the expression of HIF-1α as well as VEGF to inhibit tumor growth and angiogenesis, thereby enhancing the therapeutic efficacy of doxorubicin towards HCC.